The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Structure of Human Methionine Aminopeptidase-2 Complexed with Fumagillin
Abstract
The fungal metabolite fumagillin suppresses the formation of new blood vessels, and a fumagillin analog is currently in clinical trials as an anticancer agent. The molecular target of fumagillin is methionine aminopeptidase-2 (MetAP-2). A 1.8 Å resolution crystal structure of free and inhibited human MetAP-2 shows a covalent bond formed between a reactive epoxide of fumagillin and histidine-231 in the active site of MetAP-2. Extensive hydrophobic and water-mediated polar interactions with other parts of fumagillin provide additional affinity. Fumagillin-based drugs inhibit MetAP-2 but not MetAP-1, and the three-dimensional structure also indicates the likely determinants of this specificity. The structural basis for fumagillin's potency and specificity forms the starting point for structure-based drug design.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These nucleophilic centers are also present in DNA and other biologically relevant compounds, such as glutathione.116–121”
From Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products (2024) · cites this paper as [118]
Citations
Cites
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,796
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,011
Jones, T. A., Zou, J.-Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,616
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · Protein Engineering Design and Selection · doi:10.1093/protein/8.2.127 · Cited by 5,731
AMoRe: an automated package for molecular replacement
Navaza, J. (1994) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767393007597 · Cited by 4,941
Crystallographic R Factor Refinement by Molecular Dynamics
Brünger, A. T., Kuriyan, J., & Karplus, M. (1987) · Science · doi:10.1126/science.235.4787.458 · Cited by 1,950
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
Ingber, D. E., Fujita, T., KISHIMOTO, S., Sudo, K., KANAMARU, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,301
Serine Proteases: Structure and Mechanism of Catalysis
Kraut, J. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.001555 · Cited by 1,253
ALSCRIPT: a tool to format multiple sequence alignments
Barton, G. J. (1993) · Protein Engineering Design and Selection · doi:10.1093/protein/6.1.37 · Cited by 1,144
Research works printed but not linked: 1
- J. Wang N. Quan J. Henkin Proc. Am. Assoc. Cancer Res. 39 98 (abstr.) (1998).
Cited by
Sorted by citations
Items 301–400 of 455
Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
Farrell, P. J., Zopf, C. J., Huang, H.-J., Balakrishna, D., Holub, C., Bilakovics, J. M., Fanjul, A. N., Matuszkiewicz, J., Płonowski, A., Rolzin, P., et al. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.259028 · Cited by 9
Bengamide Analogues Show A Potent Antitumor Activity against Colon Cancer Cells: A Preliminary Study
García-Pinel, B., Porras-Alcalá, C., Cabeza, L., Ortíz, R., Prados, J. C., Melguizo, C., Cheng‐Sánchez, I., López‐Romero, J. M., & Sarabia, F. (2020) · Marine Drugs · doi:10.3390/md18050240 · Cited by 9
Zhang, X., Wang, T. T., Xu, Q. L., Xiong, Y., Zhang, L., Han, H., Xu, K., Guo, W. J., Xu, Q., Tan, R. X., et al. (2018) · Angewandte Chemie · doi:10.1002/ange.201804317 · Cited by 9
Stanimirović, Z., Ivana, P., Kulišić, Z., & Milanka, D. (2007) · Acta veterinaria · doi:10.2298/avb0703257s · Cited by 9
Pandrea, I., Mittleider, D., Brindley, P. J., Didier, E. S., & Robertson, D. L. (2005) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2004.12.006 · Cited by 9
Reversal of TNP-470-Induced Endothelial Cell Growth Arrest by Guanine and Guanine Nucleosides
Hines, J. F., Ju, R., Dutschman, G. E., Cheng, Y., & Crews, C. M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.169110 · Cited by 9
Self-citationOrally Active Fumagillin Analogues: Transformations of a Reactive Warhead in the Gastric Environment
Arico-Muendel, C. C., Blanchette, H., Benjamin, D. R., Caiazzo, T., Centrella, P. A., DeLorey, J. L., Doyle, E., Johnson, S. R., Labenski, M., Morgan, B. A., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml3003633 · Cited by 9
Vetro, J. A., Dummitt, B., & Chang, Y. (2004) · Springer eBooks · doi:10.1007/978-1-4419-8869-0_2 · Cited by 9
Kanno, T., Uehara, T., Osawa, M., Fukumoto, H., Mine, S., Ueda, K., Hasegawa, H., & Katano, H. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.100 · Cited by 9
Structure of Sch 528647: A New Antitumor Antibiotic Related to Fumagillin.
Chu, M., Mierzwa, R., HE, L., Xu, L., Patel, M. V., PATEL, D., & Chan, T. (2001) · The Journal of Antibiotics · doi:10.7164/antibiotics.54.1096 · Cited by 9
Mitra, S., Sheppard, G. S., Wang, J., Bennett, B., & Holz, R. C. (2009) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0471-2 · Cited by 9
Zum Mechanismus des weitreichenden Elektronentransports durch DNA
Giese, B., Wessely, S., Spormann, M., Lindemann, U., Meggers, E., & Michel‐Beyerle, M. E. (1999) · Angewandte Chemie · doi:10.1002/(sici)1521-3757(19990401)111:7 · Cited by 24
Pillalamarri, V., Reddy, C. G., Bala, S., Jangam, A., Kutty, V. V., & Addlagatta, A. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112883 · Cited by 8
Albayati, S., Uba, A. İ., & Yelekçi, K. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10221-7 · Cited by 8
Analyzing the catalytic role of Asp97 in the methionine aminopeptidase from Escherichia coli
Mitra, S., Job, K. M., Meng, L., Bennett, B., & Holz, R. C. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06749.x · Cited by 8
Hirst, D. J., Brandt, M. A., Bruton, G., Christodoulou, E., Cutler, L., Deeks, N. J., Goodacre, J. D., Jack, T. I., Lindon, M. J., Miah, A. H., et al. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127533 · Cited by 8
Chung, J.-M., Chung, I. Y., & Lee, Y. S. (2002) · BMB Reports · doi:10.5483/bmbrep.2002.35.2.228 · Cited by 8
Spirocyclic Scaffolds in Drug Discovery
Tice, C. M., Zheng, Y., & Singh, S. B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12291-7 · Cited by 8
Common therapeutic target for both cancer and obesity
Chang, Y. (2017) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v8.i2.102 · Cited by 8
Novel broad-spectrum inhibitors of bacterial methionine aminopeptidase
Rose, J. A., Lahiri, S. D., McKinney, D. C., Albert, R., Morningstar, M., Shapiro, A. B., Fisher, S. L., & Fleming, P. R. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.05.061 · Cited by 8
Anti-nidatory effect of vaginally administered fumagillin in the rhesus monkey
Lalitkumar, P. G., Sengupta, J., Dhawan, L., Sharma, D., Lasley, B. L., Overstreet, J. W., & Ghosh, D. (2000) · Contraception · doi:10.1016/s0010-7824(00)00158-x · Cited by 8
Majumdar, A., Ghosh, A., Datta, S. K., Prudner, B. C., & Datta, B. (2010) · Biochemistry · doi:10.1021/bi101225d · Cited by 7
Tasdan, Y., Balaji, G. R., Akhtar, N., Ilyichova, O. V., Cunliffe, T., Heras, B., Strat, L. L., Murray, J. B., Capuano, B., Scanlon, M. J., et al. (2025) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5c00016 · Cited by 7
Tyrosine nitration moderates the peptidase activity of human methionyl aminopeptidase 2
Ng, J. Y., Chiu, J., Hogg, P. J., & Wong, J. W. H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.09.035 · Cited by 7
Fumagillin-induced chromosome aberrations in mouse bone-marrow cells
Stanimirović, Z., Aleksić, N., Kulić, M., & Maletić, M. (2010) · Archives of Biological Sciences · doi:10.2298/abs1001047s · Cited by 7
RetractedArif, A., Gardner, Q.-T.-A. A., Rashid, N., & Akhtar, M. (2015) · Biologia · doi:10.1515/biolog-2015-0113 · Cited by 7
Delineation of a new structural motif involving NHN γ‐turn
Dhar, J., Kishore, R., & Chakrabarti, P. (2019) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25820 · Cited by 7
Chemotherapy of microsporidiosis: Benzimidazoles, fumagillin and polyamine analogues
Bacchi, C. J., & Weiss, L. M. (2008) · Springer eBooks · doi:10.1007/978-1-4020-7846-0_10 · Cited by 7
Structure of creatine amidinohydrolase from Actinobacillus
Padmanabhan, B., Paehler, A., & Horikoshi, M. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902010156 · Cited by 7
Chen, L., Li, J., Li, J.-Y., Luo, Q., Mao, W.-F., Shen, Q., Nan, F.-J., & Ye, Q.-Z. (2004) · PubMed · Cited by 7
Angiogenesis can be reduced without significant reduction of tumor growth.
Svensson, Å., Bäckman, U., Fuchs, D., Christofferson, R. H. B., & Azarbayjani, F. (2007) · PubMed · Cited by 7
Methionine Aminopeptidase 2 Expression in Microsporidia
Didier, E. S., Martin, A. D., Stovall, M. E., Alvarez, X. A., Mittleider, D., Green, L. C., Bowers, L. C., PLAUCHE, A. K., Didier, P. J., & Brindley, P. J. (2003) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2003.tb00632.x · Cited by 7
Crystal structure of human 17beta-HSD type 1 in ternary complex with PBRM and NADP+
Li, T., & Lin, S. X. (2018) · Worldwide Protein Data Bank · doi:10.2210/pdb6cge/pdb · Cited by 7
Auld, D. S. (2004) · Handbook of Metalloproteins · doi:10.1002/0470028637.met015 · Cited by 7
Enshasy, H. A. E. (2010) · Springer eBooks · doi:10.1007/978-3-642-11458-8_8 · Cited by 6
Sura, M. B., Peng, Y.-L., Cai, D., & Cheng, Y. (2022) · Fitoterapia · doi:10.1016/j.fitote.2022.105390 · Cited by 6
Dong, H., Liu, X., Yang, H., Zhao, J., & Zheng, Y. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01579 · Cited by 6
TNP-470: The Resurrection of the First Synthetic Angiogenesis Inhibitor
Mann-Steinberg, H., & Satchi‐Fainaro, R. (2008) · Springer eBooks · doi:10.1007/978-0-387-71518-6_35 · Cited by 6
Chavant, P., Taupin, V., Alaoui, H. E., Wawrzyniak, I., Chambon, C., Prensier, G., Méténier, G., & Vivarès, C. P. (2005) · International Journal for Parasitology · doi:10.1016/j.ijpara.2005.05.009 · Cited by 6
Lee, H. S., Kim, Y. J., Bae, S. S., Jeon, J. H., Lim, J. K., Jeong, B. C., Kang, S. G., & Lee, J.-H. (2006) · Marine Biotechnology · doi:10.1007/s10126-005-6124-8 · Cited by 6
Averill, B. A. (2003) · Elsevier eBooks · doi:10.1016/b0-08-043748-6/08165-2 · Cited by 6
Falk, H. (1999) · Angewandte Chemie · doi:10.1002/(sici)1521-3757(19991102)111:21 · Cited by 24
Parasite Metalo-aminopeptidases as Targets in Human Infectious Diseases
Aguado, M. E., Izquierdo, M., González-Matos, M., Varela, A. C., Méndez, Y., del Rivero, M. A., Rivera, D. G., & González‐Bacerio, J. (2023) · Current Drug Targets · doi:10.2174/1389450124666230224140724 · Cited by 5
Cornelius, P. K., Mayes, B. A., Petersen, J. S., Turnquist, D. J., Dufour, P. J., Dannenberg, A. J., Shanahan, J. M., & Carver, B. J. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0574 · Cited by 5
Osana, S., Tsai, C.-T., Suzuki, N., Murayama, K., Kaneko, M., Hata, K., Takada, H., Kano, Y., & Nagatomi, R. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.119901 · Cited by 5
Sendra, K. M., Watson, A., Kozhevnikova, E., Moore, A. L., Embley, T. M., & Hirt, R. P. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1011024 · Cited by 5
Drug targeting of aminopeptidases: importance of deploying a right metal cofactor
Bhat, S. Y. (2024) · Biophysical Reviews · doi:10.1007/s12551-024-01192-8 · Cited by 5
Moon, D. (2024) · Biomolecules · doi:10.3390/biom14121572 · Cited by 5
Kang, J., Ju, J., Kim, J., Ju, H., Lee, J., Lee, K. H., Lee, W.-J., Sohn, W., Kim, T.-S., & Na, B. (2015) · Protein Expression and Purification · doi:10.1016/j.pep.2015.01.003 · Cited by 5
Synthesis and bioactivity studies of covalent inhibitors derived from (-)-Chaetominine
Zhou, X., Feng, X., Wang, D., Chen, D., Wu, G., Yan, Z., Lyu, X., Wang, H., Yang, J.-M., & Zhao, Y. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.130694 · Cited by 5
Banerjee, S., & Paruthy, S. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-25001-4_22 · Cited by 5
Vetro, J. A., Dummitt, B., Micka, W. S., & Chang, Y. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20285 · Cited by 5
Impact of Marine‐DerivedPenicilliumSpecies in the Discovery of New Potential Antitumor Drugs
Vansteelandt, M., Roullier, C., Blanchet, É., Guitton, Y., Pouchus, Y. F., Ruiz, N., & Grovel, O. (2014) · doi:10.1002/9783527681501.ch03 · Cited by 5
Mekapati, S. B., & Hansch, C. H. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00225-5 · Cited by 5
Matthews, B. W. (2004) · Handbook of Metalloproteins · doi:10.1002/0470028637.met025 · Cited by 5
Differential Expression of MARCKS in C2C12 Myoblasts and Myotubes Constitutively Expressing P67
(2016) · International journal of advanced research in chemical sciences · doi:10.20431/2349-0403.0302004 · Cited by 4
Covalent chemistry in targeted protein degradation
Tan, J., Liang, Y., Shao, S., & Shen, Y. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115777 · Cited by 4
Bacterial Metalo-Aminopeptidases as Targets in Human Infectious Diseases
González‐Bacerio, J., Varela, A. C., Aguado, M. E., Izquierdo, M., Méndez, Y., del Rivero, M. A., & Rivera, D. G. (2022) · Current Drug Targets · doi:10.2174/1389450123666220316085859 · Cited by 4
Qazi, I. H., Yuan, T., Yang, S., Angel, C., & Liu, J. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1549224 · Cited by 4
Banerjee, S., & Paruthy, S. B. (2016) · Springer eBooks · doi:10.1007/978-3-319-19456-1_22-1 · Cited by 4
Lespérance, M., Barbeau, X., Roy, J., Maltais, R., Lagüe, P., & Poirier, D. (2018) · Steroids · doi:10.1016/j.steroids.2018.09.009 · Cited by 4
Heinrich, T., Zenke, F. T., Bomke, J., Gunera, J., Wegener, A. A., Friese‐Hamim, M., Hewitt, P. G., Müsil, D., & Rohdich, F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823974-2.00023-1 · Cited by 4
Parrella, P., Elikan, A. B., & Snow, J. W. (2024) · Journal of Eukaryotic Microbiology · doi:10.1111/jeu.13026 · Cited by 6
Chapter 11. Anti-angiogenesis as a therapeutic strategy for cancer
Fantl, W. J., & Rosenberg, S. (2000) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(00)35012-6 · Cited by 4
Modern Methods for the Isolation of Natural Product Receptors
Karuso, P. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00210-0 · Cited by 4
Applications in the Synthesis of Natural and Biologically Active Molecules
Cossy, J. (2014) · doi:10.1002/9781118711613.ch8 · Cited by 4
Auld, D. S. (2004) · Encyclopedia of Inorganic and Bioinorganic Chemistry · doi:10.1002/9781119951438.eibc0482 · Cited by 4
Theranostic Strategy Against Plaque Angiogenesis
Arbustini, E., & Gambarin, F. I. (2008) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2008.07.007 · Cited by 4
Sánchez, C. I., Díaz, V., Alcázar, L., Amich, J., Marín, L., & Calera, J. A. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02279-25 · Cited by 4
Schiffmann, R., Heine, A., Klebe, G., & Klein, C. D. P. (2005) · Angewandte Chemie · doi:10.1002/ange.200500592 · Cited by 3
Synthesis and investigation of cytotoxic effects of compounds derived from flurbiprofen
Gökoğlan, E., Dere, D., Bedir, İ., Yelekçi, K., Telci, D., & Küçükgüzel, Ş. G. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.135876 · Cited by 3
Meléndez‐Martínez, D., Morales-Martinez, A., Sierra-Valdez, F. J., Cossío-Ramírez, R., Lozano, O., Mayolo‐Deloisa, K., Rito‐Palomares, M., & Benavides, J. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.109049 · Cited by 3
d’Enfert, C. (2000) · Springer eBooks · doi:10.1007/978-94-015-9546-9_1 · Cited by 3
Special Issue in Honor of Professor Jon Clardy
Seyedsayamdost, M. R., & Stallforth, P. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.0c00199 · Cited by 3
Das, D., Murzin, A. G., Rawlings, N. D., Finn, R. D., Coggill, P. C., Bateman, A. G., Godzik, A., & Aravind, L. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-75 · Cited by 2
(2016) · International journal of advanced research in chemical sciences · doi:10.20431/2349-0403.0301001 · Cited by 2
Proteolytic inventory of Thermococcus kodakaraensis
Nouman, R., Naeem, R., Bashir, Q., & Masood, A. S. (2013) · African Journal of Microbiology Research · doi:10.5897/ajmrx12.007 · Cited by 2
Koshino, H., & Usui, T. (2017) · Springer eBooks · doi:10.1007/978-4-431-56529-1_6 · Cited by 2
Capturing Legionella pneumophila effector enzymes using a ubiquitin derived photo-activatable probe
Kloet, M. S., & van Noort, G. J. V. D. H. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1422034 · Cited by 2
Other Nonbiological Approaches to Targeted Cancer Chemotherapy
Avendaño, C., & Menéndez, J. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-62649-3.00011-9 · Cited by 2
COVALENT ENZYME INHIBITION IN DRUG DISCOVERY AND DEVELOPMENT
Mehdi, S. (2013) · Wiley eBooks · doi:10.1002/9781118739907.ch3 · Cited by 2
The Ring-Closing Metathesis Approach to Fumagillol
Eustache, J., & van de Weghe, P. (2004) · Strategies and tactics in organic synthesis · doi:10.1016/s1874-6004(04)80013-3 · Cited by 2
Sundström, M., Norin, M., & Edwards, A. M. (2005) · doi:10.1201/9780849361432-9 · Cited by 2
Peng, Y. Q. (2009) · Murdoch University Research Portal · Cited by 2
Protein degradation-based cancer therapy
Avendaño, C., & Menéndez, J. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818549-0.00012-1 · Cited by 1
Tsunematsu, Y., Ogata, Y., Niwa, K., Ogata, N., Kobayashi, S., Sato, M., Matsushita, T., Shizu, R., Yoshinari, K., Mori, M., et al. (2025) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbaf091 · Cited by 1
Expanding the landscape of covalent drug discovery: irreversible targeting of non‐cysteine residues
Srinivasan, B., & Taylor, J. B. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70604 · Cited by 2
Okura, Y., Saito‐Nakano, Y., Balia, A. G., Suhaimi, N. S. B., Ando, C., Ogata, N., Ikeda, T., Sato, T., Kano, K., Mishiro‐Sato, E., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c18554 · Cited by 1
Nanomedicine for Treatment of Cardiovascular Diseases and Stroke
Kumar, N., & Kumar, R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-323-26433-4.00005-1 · Cited by 1
Aspergillus fumigatus und Angiogenese. Von einer Zufallsentdeckung zum Rationalen Drug‐Design
Klein, C. D. P. (2007) · Pharmazie in unserer Zeit · doi:10.1002/pauz.200700242 · Cited by 1
(2016) · International journal of advanced research in chemical sciences · doi:10.20431/2349-0403.0303001 · Cited by 1
(2016) · International journal of advanced research in chemical sciences · doi:10.20431/2349-0403.0304001 · Cited by 1
Bala, S., Reddi, B., & Addlagatta, A. (2022) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2022.140881 · Cited by 1
Other Approaches to Targeted Therapy
Avendaño, C., & Menéndez, J. C. (2008) · Elsevier eBooks · doi:10.1016/b978-0-444-52824-7.00010-x · Cited by 1
Probing Protein Function with Small Molecules
Gough, J. D., & Crews, C. M. (2007) · Springer eBooks · doi:10.1007/978-3-540-37635-4_5 · Cited by 1
Self-citationJørgensen, A. T., Sørensen, M. D., Björkling, F., & Liljefors, T. (2003) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1026149810619 · Cited by 1
Chemistry meets Biology: Chemical Approaches to the Study of Biology
Strømgaard, K. (2004) · ChemBioChem · doi:10.1002/cbic.200400301 · Cited by 1
Usui, T., & Osada, H. (2000) · Springer eBooks · doi:10.1007/978-4-431-65927-3_6 · Cited by 1
Development of covalent probes to capture Legionella pneumophila effector enzymesPreprint
Kloet, M. S., Mukhopadhyay, R., Mukherjee, R., Misra, M., Jeong, M., Ormeño, C. M. P. T., Moutsiopoulou, A., Tjokrodirijo, R. T. N., van Veelen, P. A., Shin, D., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.19.585531 · Cited by 1
Perfluorocarbon Nanoparticles: A Multidimensional Platform for Targeted Image‐Guided Drug Delivery
Lanza, G. M., Caruthers, S. D., Schmieder, A. H., Winter, P. M., Cyrus, T., & Wickline, S. A. (2011) · doi:10.1002/9780470767047.ch30
Metadata
- Authors
- Liu, S., Widom, J., Kemp, C. W., Crews, C. M., & Clardy, J.
- Affiliations
- Cornell University (US)
- Corresponding author
- Clardy, Jon
- Venue
- Science
- Published
- 1998-11-13
- Volume
- 282
- Issue
- 5392
- Pages
- 1324-1327
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2085785716
- Cited by
- 440
- References
- 28
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 14 · 2023: 14 · 2022: 12 · 2021: 13 · 2020: 13 · 2019: 13 · 2018: 13 · 2017: 5 · 2016: 10 · 2015: 14 · 2014: 14 · 2013: 16 · 2012: 13
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA024487, CA 59021, R01CA059021, CA-24487)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- methionine aminopeptidase 2, fumagillin, crystal structure, enzyme-inhibitor complex, antivascular agents, anticancer agents, enzyme specificity, structure-based drug design
- MeSH terms
- Amino Acid Sequence, Aminopeptidases, Binding Sites, Cyclohexanes, Fatty Acids, Unsaturated, Humans, Hydrogen Bonding, Metalloendopeptidases, Models, Molecular, Molecular Sequence Data, Protein Conformation, Sesquiterpenes, Sequence Alignment, Protein Structure, Secondary, Crystallography, X-Ray
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review